Generate a tailored SOP for Dr. Christopher Nicol. Improve your application with a focused, well-structured draft.
Christopher Nicol is an Associate Professor at Queen's Cancer Research Institute specializing in topics related to cancer biology, pharmacology, and toxicology. He actively engages in teaching both graduate and undergraduate courses. His graduate course offerings include Cancer Biology (PATH823), Experimental Cancer Therapeutics (PATH822), and the co-led Breast Cancer session Mechanistic Basis Disease (PATH430/826). He also oversees courses related to Drug Transport Pharmacogenetics & Pharmacogenomics, covering key principles in Drug Discovery and Development (BMED809) and Carcinogenesis II, emphasizing epigenetic mechanisms affecting mechanistic toxicology (BMED815). At the undergraduate level, he serves as Course Coordinator for fourth-year honors research projects in cancer biology and genetics (CANC499), and leads topics centered around drug transporters and their role in carcinogenesis and xenobiotic disposition (PHAR416). Nicol's prior teaching experience includes Chemotherapy-induced malignancies and Cancer Biology & Therapeutics (CANC440).
Department of Computing offers research-based, project-based, and course-based patterns.